Management of cases of COVID-19 infection with acute respiratory failure: a narrative review

Omar Rezk Alshaer, Abdullah Obaid Binobaid, Ruzan Mohammed Saleh, Abdelrahman Abdrabou Eldabbari, Nasser Ibrahim Aldawsari, Mubarak Mohammed Alasmari, Abdulkarim Thumail Alshamry, Aisha Nour Almutairi, Musab Salem Alluqmani, Rayan Saeed Alzahrani, Mohammed Mana Alqahtani


Corona viruses are enveloped, positive-sense, single-stranded large RNA viruses that affect humans and many animals. About 5% of COVID-19 patients need ICU admission due to ARDS, with a case fatality rate varying from 30% to 60%. Some patients need help other than supplementary oxygen, such as non-invasive ventilation or intubation. Before deciding the appropriate respiratory support for acute respiratory failure patients, concerns regarding the dangers of various treatments should be considered. During the treatment of COVID-19 patients, all respiratory therapies face a risk of aerosol-generating procedures. When treating COVID-19 patients, the priority and consideration should be personal safety devices and environmental control/engineering.


COVID-19, Acute respiratory distress syndrome, Corona pandemic, Oxygen therapy

Full Text:



Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020; 92(4):401-2.

World health organization director-general’s opening remarks at the media briefing on COVID-19–11 March 2020. Available at: dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed on 30 March 2021.

Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966:1(7428):76-7.

WHO Coronavirus disease (COVID-19) Dashboard. Available at: diseases/novel-coronavirus-2019. Accessed on 30 March 2021.

Lupia T, Scabini S, Pinna SM, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Global Antimicrob Resist. 2020;21:22-7.

Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020;180(7):934-43.

World Health Organization Covid-19 Infection. Available at: diseases/novel-coronavirus-2019. Accessed on 30 March 2021.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020; 395(10229):1054-62.

Han W, Quan B, Guo Y, Zhang J, Lu Y, Feng G, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. J Med Virol. 2020;92(5):461-3.

Zhang T, Sun LX, Feng RE. Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019. Chinese J Tuberc Respir Dis. 2020;43:E040-5.

Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resuscit. 2020;22(2):95.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-81.

Wang Z, Deng H, Ou C, Liang J, Wang Y, Jiang M, et al. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: A systematic review and meta-analysis without cases duplication. Medicine. 2020;99(48):56-9.

Gao YD, Ding M, Dong X, Zhang JJ, Kursat AA, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2): 428-55.

Severe Covid-19 GWAS group. Genomewide association study of severe Covid-19 with respiratory failure. New Eng J Med. 2020;383(16):1522-34.

England JT, Abdulla A, Biggs CM, Lee AY, Hay KA, Hoiland RL, et al. Weathering the COVID-19 storm: lessons from hematologic cytokine syndromes. Blood Rev. 2020;15:100707-9.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.

Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395(10224):e35-6.

Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive care medicine. 2020;46(6):1105-8.

Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992-1000.

Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translat Res. 2020;220:1-3.

Bhattacharyya R, Iyer P, Phua GC, Lee JH. The interplay between coagulation and inflammation pathways in COVID-19-associated respiratory failure: a narrative review. Pulmon Ther. 2020;25:1-7.

Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LF, de Oliveira EP, Saldiva PH, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;18(6):1517-9.

Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195(3):331-8.

Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomized controlled trials. Lancet Respir Med. 2014;2(8):611-20.

Pan C, Chen L, Lu C, Zhang W, Xia JA, Sklar MC, et al. Lung recruitability in COVID-19 associated acute respiratory distress syndrome: a single-center observational study. Am J Respir Crit Care Med. 2020;201(10):1294-7.

Bos LD, Paulus F, Vlaar AP, Beenen LF, Schultz MJ. Subphenotyping ARDS in COVID-19 patients: consequences for ventilator management. Ann Am Thorac Soc. 2020;10:52-9.

Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, et al. Liberal or conservative oxygen therapy for acute respiratory distress syndrome. New Eng J Med. 2020;382(11):999-1008.

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E. Sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intens Cara Med. 2020;54:63-9.

Wilcox SR. Management of respiratory failure due to covid-19. BMJ. 2020;369:m1786.

Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438-42.

Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L, et al. Non-invasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med. 2017;195(1):67-77.

Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth. 2020;67(5):568-76.

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. American journal of respiratory and critical care medicine. 2020;201(10):1299-300.

Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319(7):698-710.

Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PloS one. 2012;7(4):e35797.

National health commission of the People’s Republic of China. Diagnosis and treatment protocol for COVID-19. Available at: Accessed on 30 March 2021.

Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40(5):351-60.

Chen C, Qi F, Shi K, Li Y, Li J, Chen Y, et al. Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019. Clin Transl Med. 2020;10(2):e35.

Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, Møller MH, Annane D, et al. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ. 2018;10:362-5.

Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014-5.

Higher mortality rate in ventilated COVID-19 patients in large sample. Available at: https://www.medscape. com/viewarticle/928605. Accessed on 30 March 2021.